TELA Bio (TELA) Other financing activities (2018 - 2026)

TELA Bio has reported Other financing activities for 9 years, with the latest figure at $27000.0 in Q1 2026.

• On a quarterly basis, Other financing activities fell 55.0% year-over-year to $27000.0 in Q1 2026; TTM through Jun 2026 was $3.5 million, a 2961.74% increase from a year earlier, with the FY2025 full-year figure at $3.6 million, up 1164.77% from the prior year.
• Other financing activities was $27000.0 for Q1 2026 at TELA Bio, down from $3.4 million in the prior quarter.
• The five-year high for Other financing activities was $3.4 million in Q4 2025, with the low at $1000.0 in Q3 2023.
• Average Other financing activities over 5 years is $532071.4, with a median of $50000.0 recorded in 2024.
• The sharpest annual moves came in 2023 and 2024: Other financing activities plunged 99.03% in 2023, then soared 5400.0% in 2024.
• Over 5 years, Other financing activities stood at $103000.0 in 2022, then tumbled by 74.76% to $26000.0 in 2023, then jumped by 111.54% to $55000.0 in 2024, then jumped by 6170.91% to $3.4 million in 2025, then sank by 99.22% to $27000.0 in 2026.
• The last three Other financing activities figures came in at $27000.0 (Q1 2026), $3.4 million (Q4 2025), and $45000.0 (Q3 2025), per Business Quant data.